Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01690780
Other study ID # R-11-340
Secondary ID 18091
Status Completed
Phase N/A
First received September 13, 2012
Last updated July 15, 2014
Start date September 2012
Est. completion date February 2014

Study information

Verified date July 2014
Source Lawson Health Research Institute
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

Children 5-17 years of age who have sustained a non-operative distal forearm (radius and/or ulna) or clavicular fracture will be randomized to receive either ibuprofen or oral morphine as needed for pain relief for the first 24 hours following discharge from the emergency department. Pain will be assessed using the self-report Faces pain scale revised (FPS-R). We hypothesize that oral morphine will result in greater pain relief than ibuprofen.


Recruitment information / eligibility

Status Completed
Enrollment 183
Est. completion date February 2014
Est. primary completion date February 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 5 Years to 17 Years
Eligibility Exclusion Criteria:

- patients with known hypersensitivity to either ibuprofen or morphine

- chronic users of NSAIDS or opioids

- fractures requiring operative management

- associated injuries requiring analgesia

- poor English fluency

- pregnancy

Inclusion Criteria:

- All patients aged 5 to 17 years with a non-operative forearm or distal radius fracture

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Drug:
Oral morphine
oral morphine 0.5 mg/kg (max 10 mg) every 6 hours as needed for 24 hours
Ibuprofen
Ibuprofen 10 mg/kg (max 600 mg) every 6 hours as needed for pain (maximum 4 doses) for 24 hours following discharge from the emergency department

Locations

Country Name City State
Canada London Health Sciences Center London Ontario

Sponsors (1)

Lead Sponsor Collaborator
Naveen Poonai

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Faces Pain scale - revised The primary outcome variable is the pre-post intervention difference in pain scores as measured by self-reported Faces Pain Scale - Revised (FPS-R) for the first 24 hours post-fracture management following the as needed administration of the study drugs. 30 minutes post intervention compared to baseline No
Secondary Acetaminophen doses The secondary outcome variable is the number of breakthrough acetaminophen doses required/taken by the participant for the first 24 hours post-fracture management 24 hours No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02366221 - Upper-Extremity Bone or Joint Surgery: Long Term Outcome